Health-related quality of life in relapsing remitting multiple sclerosis (RRMS) patients treated with placebo or BG-12 (dimethyl fumarate): comparison with other medical conditions

被引：0
|
作者：
Sarda, S.
Phillips, G.
Gaebler, J. A.
Kurukulasuriya, N. C.
机构：
来源：
MULTIPLE SCLEROSIS JOURNAL | 2013年 / 19卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：290 / 290
页数：1
相关论文
共 50 条
  • [31] Clinical Efficacy and Safety of Oral Bg-12 (Dimethyl Fumarate) In Relapsing-Remitting Multiple Sclerosis (RRMS): An Integrated Analysis of the Phase 3 Define and Confirm Studies
    Bar-Or, A.
    Gold, R.
    Fox, R. J.
    Havrdova, E.
    Selmaj, K.
    Kurukulasuriya, N. C.
    Yang, M.
    Raghupathi, K.
    Novas, M.
    Sweetser, M. T.
    Viglietta, V.
    Dawson, K. T.
    Phillips, J. T.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 (12) : 1828 - 1828
  • [32] Safety and Tolerability of BG-12 (Dimethyl Fumarate) in Patients with Relapsing-Remitting Multiple Sclerosis: An Integrated Analysis of Phase 2 and 3 Placebo-Controlled Studies
    Phillips, J. Theodore
    Fox, Robert
    Gold, Ralf
    Havrdova, Eva
    Kappos, Ludwig
    Raghupathi, Kartik
    Yuan, Huixing
    Viglietta, Vissia
    Sheikh, Sarah
    Dawson, Katherine
    Novas, Mark
    Sweetser, Marianne
    Selmaj, Krzysztof
    NEUROLOGY, 2013, 80
  • [33] Effects of BG-12 on Quality of Life in Patients with Relapsing-Remitting Multiple Sclerosis: Findings from the DEFINE Study
    agarwal, Sonalee
    Kappos, Ludwig
    Gold, Ralf
    Arnold, Douglas
    Bar-Or, Amit
    Giovannoni, Gavin
    Selmaj, Krzysztof
    Kong, Jessica
    Sheikh, Sarah
    Dawson, Katherine
    NEUROLOGY, 2012, 78
  • [34] BG-12 (Dimethyl Fumarate) Treatment for Relapsing-Remitting Multiple Sclerosis (RRMS) Increases the Proportion of Patients Free of Measured Clinical and Neuroradiologic Disease Activity in the Phase 3 Studies
    Havrdova, Eva
    Gold, Ralf
    Fox, Robert
    Kappos, Ludwig
    Phillips, J. Theodore
    Zhang, Annie
    Kurukulasuriya, Nuwan
    Sheikh, Sarah
    Viglietta, Vissia
    Dawson, Katherine
    Giovannoni, Gavin
    NEUROLOGY, 2013, 80
  • [35] Effect of BG-12 in subgroups of patients with relapsing-remitting multiple sclerosis: findings from the CONFIRM (Comparator and an Oral Fumarate in Relapsing-Remitting Multiple Sclerosis) study
    Hutchinson, M.
    Fox, R. J.
    Miller, D.
    Phillips, J. T.
    Kita, M.
    Havrdova, E.
    Yang, M.
    Zhang, R.
    Novas, M.
    Viglietta, V.
    Dawson, K. T.
    JOURNAL OF NEUROLOGY, 2012, 259 : S105 - S106
  • [36] Effect of BG-12 in subgroups of patients with relapsing-remitting multiple sclerosis: findings from the CONFIRM (comparator and an oral fumarate in relapsing-remitting multiple sclerosis) study
    Hutchinson, M.
    Fox, R. J.
    Miller, D.
    Phillips, J. T.
    Kita, M.
    Havrdova, E.
    O'Gorman, J.
    Yang, M.
    Novas, M.
    Viglietta, V.
    Dawson, K. T.
    EUROPEAN JOURNAL OF NEUROLOGY, 2012, 19 : 355 - 355
  • [37] Psychosocial and Medical Determinants of Health-related Quality of Life in Patients with Relapsing-Remitting Multiple Sclerosis
    Rahimian Boogar, Isaac
    Talepasand, Siavash
    Jabari, Mohammad
    NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY, 2018, 55 (01): : 29 - 35
  • [38] Clinical Efficacy of BG-12 (Dimethyl Fumarate) for Relapsing-Remitting Multiple Sclerosis (RRMS) According to Prior Therapy: An Integrated Analysis of the Phase 3 DEFINE and CONFIRM Studies
    Hutchinson, Michael
    Gold, Ralf
    Fox, Robert
    Havrdova, Eva
    Giovannoni, Gavin
    Zhang, Annie
    Hotermans, Christophe
    Stephan, Monica
    Dawson, Katherine
    Bar-Or, Amit
    NEUROLOGY, 2013, 80
  • [39] An integrated analysis of safety and tolerability of BG-12 (dimethyl fumarate) in patients with relapsing-remitting multiple sclerosis from phase 2 and 3 placebo-controlled studies
    Phillips, J. T.
    Fox, R. J.
    Gold, R.
    Havrdova, E.
    Kappos, L.
    Raghupathi, K.
    Yuan, H.
    Viglietta, V.
    Sheikh, S. I.
    Dawson, K. T.
    Novas, M.
    Sweetser, M. T.
    Selmaj, K.
    JOURNAL OF NEUROLOGY, 2013, 260 : S75 - S75
  • [40] Efficacy and safety of BG-12 (dimethyl fumarate) and other disease-modifying therapies for the treatment of relapsing-remitting multiple sclerosis: a systematic review and mixed treatment comparison
    Hutchinson, Michael
    Fox, Robert J.
    Havrdova, Eva
    Kurukulasuriya, Nuwan C.
    Sarda, Sujata P.
    Agarwal, Sonalee
    Siddiqui, Mohd Kashif
    Taneja, Ankush
    Deniz, Baris
    CURRENT MEDICAL RESEARCH AND OPINION, 2014, 30 (04) : 613 - 627
12345